Catalyst Wire Dossier Catalyst Wire Dossier

Actitob

tobramycin inhalation solution · Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Actitob, covering 2014-06-20 to 2020-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® [Phase 3]

See pricing